Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Kaposiform hemangioendothelioma (KHE) may look like a birthmark, but is actually a benign tumor of a child's blood vessels. It's not a cancer; rather, KHE is a vascular anomaly — an abnormal growth of blood vessels. Because it's benign, KHE can grow but doesn't spread to other locations in a child's body.
Because kaposiform hemangioendotheliomas are so rare, very few doctors have experience diagnosing and treating them. The Vascular Anomalies Center (VAC) at Boston Children's has evaluated more children with KHE than any other hospital in the world. The VAC's 25 physicians — representing 16 medical and surgical specialties — draw on those experiences to redefine the best therapies and achieve better long-term outcomes for children with KHE.
The VAC clinic takes an interdisciplinary approach to care with every child they see. It's not uncommon for children on their first visit to the clinic to be evaluated by a whole VAC team at the same time. From there, the team works with you to develop and carry out a comprehensive and coordinated care plan that matches your child's specific needs.
The team brings in the expertise of other Boston Children's departments and services as necessary to provide your child with the best care.
Kaposiform hemangioendothelioma: Reviewed by Cameron C. Trenor III, MD, © Boston Children's Hospital, 2016
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”